These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2475690)

  • 21. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.
    Speders S; Sosna J; Schumacher A; Pfennigsdorf G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S47-9. PubMed ID: 2475686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients.
    Pannarale G; Puddu PE; Campbell SV; Collauto F; Stazi F; Reale A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S53-6. PubMed ID: 1377307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of two formulations of verapamil.
    Hla KK; Henry JA; Latham AN
    Br J Clin Pharmacol; 1987 Nov; 24(5):661-4. PubMed ID: 3435694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of sustained-release formulations of nicardipine and verapamil for mild to moderate systemic hypertension.
    Gradman AH; Frishman WH; Kaihlanen PM; Wong SC; Friday KJ
    Am J Cardiol; 1992 Dec; 70(20):1571-5. PubMed ID: 1466325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg.
    Böhmer F; Barousch R; Reinfrank J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S45-6. PubMed ID: 2475685
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sustained-release verapamil on 24-hour ambulatory blood pressure and on pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Mores N; Folli G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S31-3. PubMed ID: 2475681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trial.
    Weber MA; Prisant LM; Black HR; Messerli FH
    Am J Geriatr Cardiol; 2004; 13(3):131-6. PubMed ID: 15133416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.